Company / Tangible Book Value per Share
Vivos Therapeutics, Inc. Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$1.71
FY2025
5-year range
-$1.71 / $24.65
FY2021-FY2025
Trend
-28.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $24.65 to $-1.71 over the past 2 years.
Based on SEC 10-K filings.
-1.71 in FY2025.
Declined from $24.65 to $-1.71 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 28.8% year-over-year.
- Peak tangible book value per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.71 | -28.8% |
| FY2024 | -$1.33 | -105.4% |
| FY2023 | $24.65 | +2399.7% |
| FY2022 | $0.99 | +27.6% |
| FY2021 | $0.77 | +271.3% |
| FY2020 | -$0.45 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026